Načítá se...
Liraglutide preconditioning attenuates myocardial ischemia/ reperfusion injury via homer1 activation
Myocardial infarction (MI) is one of most common cardiovascular diseases, and ischemia/reperfusion (I/R) injury is one of the risk factors for severe myocardial injury and dysfunction, even leading to high mortality of myocardial infarction. Liraglutide, a novel glucagon-like peptide 1 (GLP-1) analo...
Uloženo v:
| Vydáno v: | Aging (Albany NY) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7993747/ https://ncbi.nlm.nih.gov/pubmed/33535171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.202429 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|